1.
Guzmán-de-Villoria J,
Fernández-García P,
Mateos-Pérez J,
Desco M.
Estudio de la perfusión cerebral mediante técnicas de susceptibilidad magnética: técnica y aplicaciones.
Radiología.
2012;54(3):208-220.
2.
Essig M,
Shiroishi M,
Nguyen T,
Saake M,
Provenzale J,
Enterline D et al.
Perfusion MRI: The Five Most Frequently Asked Technical Questions.
American Journal of Roentgenology.
2013;200(1):24-34.
3.
Covarrubias DJ,
Rosen BR,
Lev MH.
Dynamic magnetic resonance perfusion imaging of brain tumors.
Oncologist.
2004;9:528-37.
4.
Sanghvi D.
Post-treatment imaging of high-grade gliomas.
Indian Journal of Radiology and Imaging.
2015;25(2):102.
5.
Wang L,
Leach J,
Breneman J,
McPherson C,
Gaskill-Shipley M.
Critical Role of Imaging in the Neurosurgical and Radiotherapeutic Management of Brain Tumors.
RadioGraphics.
2014;34(3):702-721.
6.
Cha S,
Knopp EA,
Johnson G,
Wetzel SG,
Litt AW,
Zagzag D.
Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.
Radiology 2002;223(1): 11–29.
7.
Liao W,
Liu Y,
Wang X,
et al.
Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast- enhanced perfusion magnetic resonance imaging.
Acta Radiol 2009;50(2):217–225.
8.
Brandes AA,
Tosoni A,
Spagnolli F,
et al.
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.
Neuro Oncol 2008;10(3):361–367.
9.
Kumar AJ,
Leeds NE,
Fuller GN,
Van Tassel P,
Maor MH,
Sawaya RE,
et al.
Malignant gliomas: MR imaging spectrum of radiation therapy‐ and chemotherapy‐induced necrosis of the brain after treatment.
Radiology 2000;217:377‐84.
10.
Abrigo J,
Fountain D,
Provenzale J,
Law E,
Kwong J,
Hart M et al.
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Cochrane Database of Systematic Reviews.
2018;.
11.
Jain K,
Sahoo P,
Tyagi R,
Mehta A,
Patir R,
Vaishya S et al.
Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI.
Clinical Radiology.
2015;70(10):1128-1135.
12.
Ryoo I,
Choi S,
Kim J,
Sohn C,
Kim S,
Shin H et al.
Cerebral Blood Volume Calculated by Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Preliminary Correlation Study with Glioblastoma Genetic Profiles.
PLoS ONE.
2013;8(8):e71704.
13.
Mourad A,
Mohammad H,
Sayed M,
Ragae M.
What’s the clinical significance of adding diffusion and perfusion MRI in the differentiation of glioblastoma multiforme and solitary brain metastasis?.
The Egyptian Journal of Radiology and Nuclear Medicine.
2017;48(3):661-669.
14.
Zhang H,
Rödiger L,
Shen T,
Miao J,
Oudkerk M.
Perfusion MR imaging for differentiation of benign and malignant meningiomas.
Neuroradiology.
2008;50(6):525-530.